The megakaryocytic (MK) and erythroid lineages are tightly associated during differentiation and are generated from a bipotent megakaryocyte-erythroid progenitor (MEP). In the mouse, a primitive MEP has been demonstrated in the yolk sac. In human, it is not known whether the primitive MK and erythroid lineages are generated from a common progenitor or independently. Using hematopoietic differentiation of human embryonic stem cells on the OP9 cell line, we identified a primitive MEP in a subset of cells co-expressing glycophorin A (GPA) and CD41 from day 9 to day 12 of co-culturing. This MEP differentiates into primitive erythroid (GPA 
Abstract
The megakaryocytic (MK) and erythroid lineages are tightly associated during differentiation and are generated from a bipotent megakaryocyte-erythroid progenitor (MEP). In the mouse, a primitive MEP has been demonstrated in the yolk sac. In human, it is not known whether the primitive MK and erythroid lineages are generated from a common progenitor or independently. Using hematopoietic differentiation of human embryonic stem cells on the OP9 cell line, we identified a primitive MEP in a subset of cells co-expressing glycophorin A (GPA) and CD41 from day 9 to day 12 of co-culturing. This MEP differentiates into primitive erythroid (GPA and thrombopoietin receptor (MPL) are closely related. They are homodimeric class I cytokine receptors and both require JAK2 for signaling 3, 4 . Numerous transcription factors, such as GATA2, GATA1, FOG1, TAL1/SCL, GFI1B, and NFE2, are critical for both erythroid and MK development [5] [6] [7] , while others are more dedicated for unilineage differentiation, such as the erythroid EKLF (KLF1) 8, 9 and MYB 10 or the MK FLI1 11 , GABPA 12 and AML1 13 .
Studies of adult hematopoiesis, both in human and mice, have shown that the erythroid and MK lineages arise from a bipotential megakaryocyte-erythroid progenitor (MEP) [14] [15] [16] , a separate entity with no lymphoid and granulo-monocytic potential 17 . The precise hierarchical relationship between the MEP and other progenitors is controversial since it has been suggested that MEP may directly arise from a multipotent hematopoietic stem cell 18 . The erythroid and MK lineages are also tightly associated during development as a primitive MEP has been detected in the mouse yolk sac 19 . Due to limited availability of embryonic samples collected before the onset of definitive hematopoiesis, it is not known whether a MEP also exists during human primitive hematopoiesis. One way to overcome these limitations has been to use human embryonic stem cells (hES) to model in vitro the very early developmental stages of hematopoiesis 20 . Indeed, it is now possible to efficiently produce erythroid and MK cells from hES cells [21] [22] [23] [24] [25] .
In the present study, we demonstrate that the primitive erythroid and MK lineages arise from a common MEP bipotent progenitor. Expression profiling allowed us to identify the gene expression signature of this progenitor and of its descendants, thus establishing a novel model for the study of erythroid and MK differentiation.
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MATERIALS AND METHODS

Cell lines and culture media
H1 (NIH code WA01) and H9 hES (NIH code WA09) cell lines were obtained from WiCell
Research Institute (Madison, WI, USA). Most experiments were performed with the H1 cell line. Cells were maintained in an undifferentiated state on mouse embryonic fibroblasts (MEF) in hES medium consisting of Dulbecco modified Eagle /F12 medium supplemented with 20% knock-out serum replacement, 0.1 mM of minimum essential media (MEM) non essential amino acids solution, 2 mM L-glutamine, 50 U/mL penicillin, 50 µg/mL streptomycin (all from Gibco-Invitrogen, Cergy Pontoise, France), 0.1 mM β-mercaptoethanol (Sigma-Aldrich, Saint Quentin Fallavier, France) and 10 ng/mL of human basic fibroblast growth factor (bFGF) (Peprotech, Neuilly-Sur-Seine, France). For this study, H1 and H9 hES cells were used from passages 25 to 60. The mouse OP9 (Riken Institute, Osaka University, Osaka, Japan) and mouse MS5 stromal cell lines were used as feeder layers.
Antibodies and growth factors
Antibodies and their suppliers are provided as supplementary data (Table S1 ). Recombinant human hematopoietic cytokines were used at the following concentrations: EPO, 2 U/mL (OrthoBiotech, Paris, France); interleukin-3 (IL-3), 100 U/mL (generous gift from Novartis, Basel, Switzerland); SCF, 50 ng/mL (generous gift from Amgen, Thousand Oaks, CA, USA) and TPO, 50 ng/mL (generous gift from Kyrin laboratories, Tokyo, Japan).
hES differentiation on OP9 cells
To induce differentiation, hES cells were dissociated mechanically and seeded as small clumps onto a confluent OP9 stromal cell layer, previously treated with mitomycin C (SigmaAldrich) for 3 hrs. Cells were cultured in MEM medium containing 20% hES-tested FBS (Hyclone Laboratories). Medium was changed every 3 to 4 days. Growth factors were added at day 7 at indicated concentrations. At different time points, suspension and adherent cell fractions of the co-culture were harvested by treatment with 0.05% trypsin-EDTA solution (Gibco-Invitrogen) for 3 min and subjected to cell sorting, functional and molecular assays ( Figure S1 ). 
Flow cytometry and cell sorting
For cell surface marker identification, single cell suspension containing both OP9 and hES cells were incubated for 30 min at 4°C with the different conjugated monoclonal antibodies (MoAbs) and then washed twice. Cells were stained with 7-actinomycin D (7-AAD) (SigmaAldrich) and immediately analyzed with a FacSort flow cytometer (Becton Dickinson, San Jose, CA, USA). For cell sorting, cell populations at different stages of differentiation (between 9 and 14 days of co-culture) were sorted on a FacsDiva cell sorter (Becton Dickinson). DNA content of hES-derived MKs was measured by propidium iodide staining after 9 to 16 days of hES/OP9 co-culturing.
Quantification of hematopoietic progenitors in semi-solid cultures
Sorted cell populations were plated in triplicate at a density of 1 to 3 x 10 3 cells/mL in human methycellulose medium H4434 (Stem Cell Technologies, Vancouver, BC, Canada).
Progenitor-derived hematopoietic colonies were scored after 9 to 14 days. Alternatively, sorted cells from different populations were grown at a density of 1 to 3 x 10 3 cells/mL in serum-free fibrin clots in presence of the following cytokines: TPO (10 ng/mL), SCF (50 ng/mL), IL-3 (10 UI/mL) and EPO (1 U/mL) 14 . MK colonies were scored after 5 to 7 days by indirect immuno-alkaline phosphatase labeling using an anti-GPIb MoAb (anti-CD42a) (clone GN287) or anti-GPIIb MoAb.
Single cell assay for combined erythroid and megakaryocytic potential
The MS5 cells were cultured for 24 hrs to confluence on 96 flat microwell plates. After 12 days, GPA + CD41 + cells were sorted from hES /OP9 co-cultures and seeded on a MS5 feeder layer at one cell per well in medium containing hES-tested FBS and a combination of SCF, EPO, TPO and IL-3. After 5 days, proliferating clones were identified under an inverted microscope; at day 7 and day 12 cells were labeled with directly conjugated anti-GPA and anti-CD41 MoAbs and analyzed by flow cytometry.
Immunocytochemistry
Cultured MK were layered on poly-L-lysine-coated slides (Menzel-Glaser, Braunschweig, Germany) for 1 hr. Cells were then fixed with 2% paraformaldehyde for 5 min, permeabilized with 0.1% Triton X-100 and incubated with a rabbit anti-Von Willebrand factor (vWF) polyclonal antibody (Tebu, Le Perray-en-Yvelines, France) for 1 hr. After three washes, cells were incubated with the appropriate secondary antibodies and then stained with DAPI (4,6 diamidino-2-phenylindole).
Cytospin preparation and cytological staining
Sorted cell populations were centrifuged onto slides for 3 min at 500 rpm (Cytospin II, Thermo, Shandon, USA). Smears were stained with May-Grünwald-Giemsa.
RNA isolation, RT-PCR and quantitative RT-PCR
Total RNA was extracted with Qiagen (Gibco-Invitrogen) columns according to the manufacturer's recommendations. RNA quantification was assessed with NanoDrop Nd-1000 UV/Vis (Labtech France, Palaiseau, France). A total of 1 µg of RNA was reverse transcribed into cDNA as previously described 26 . The resulting synthesized cDNA was amplified using the TaqMan Universal PCR Master Mix (Applied Biosystems, Courtaboeuf, France) containing the specific primers (1.2 µM) and probe (0.1 µM). Quantitative PCR was performed on a 7500 Real Time PCR System (Applied Biosystems) with standard cycling conditions. Expression levels of all the genes were normalized to the expression of the tata box-binding protein (TBP), scored as one of the most stable genes by GeNorm analysis 27 . Quantification was done with the Pfaffl's method, taking into account the amplification efficiencies of each primer gene couple 28 . Relative expression ratios were calculated by reporting values to one of the tested conditions. Primers and probes were those publicly available on the RTPrimerDB primer database (http://medgen.ugent.be/rtprimerdb/) or were derived from an in-house in silico design.
Single-cell quantitative real-time PCR
Cells generated from hES/OP9 co-cultures were sorted according to their distinctive expression of hematopoietic antigens and directly collected as single cell in a PCR plate containing 9 μL RT-mixture as previously described 26 
RESULTS
Simultaneous generation of erythrocytes and megakaryocytes bearing features of primitive hematopoiesis by co-culture of human embryonic stem cells with OP9 cells
To induce the development of the erythroid and MK lineages, we used a two-step protocol in which undifferentiated H1 or H9 hES cells were co-cultured with OP9 stromal cells 29, 30 ( Figure S1 ). In the first step, hES cells were grown for 7 days without growth factors, before adding a cocktail of cytokines (EPO, TPO, SCF and IL-3). Using this experimental protocol, erythroid and MK differentiation (Figures 1 and 2 ) was efficiently achieved between day 9 and day 14 of co-culture. This differentiation preceded the principal wave of myelopoiesis that occurred after day 14 ( Figure S2 ) as previously reported for murine and hES cell differentiation 31, 32 .
Next, we determined the maturation stages of erythroid and MK cells during time. . Three main types of hematopoietic colonies were seen. Primitive erythroid colonies (Ery-P) grown in semi-solid medium contained usually 10-100 large highly hemoglobinized erythroblasts ( Figure 4D ) at day 12 in semi-solid medium. These colonies were morphologically distinguishable from BFU-E colonies derived from definitive erythropoiesis and found at later days of co-culture ( Figure 4D ). MK colonies were identified after CD42 or CD41 staining in plasma clot cultures ( Figure 4D ). CFU-MK-derived colonies were composed of cluster of large cells (2 to 20 cells), which were subjected to rapid lysis after 5 to 7 days. These colonies differed from cord blood and adult CFU-MK-derived colonies by a low staining with the anti-CD42 MoAb ( Figure 4D and data not shown). Mixed erythro-MK colonies had a distinguishable morphology. They had the appearance of Ery-P with the presence of a few large MKs, usually seen at the periphery ( Figure 4D ). These mixed colonies were still observed when cells were plated at low concentration (1 x 10 3 cells/mL) suggesting that they were not the result of confluence of two colonies. These MEP-derived colonies by a down regulation of "erythroid" genes (EPOR and KLF1). In contrast, erythroid differentiation was characterized by a down regulation of "MK" genes together with an induction of "erythroid" genes. Among the genes associated with differentiation in both lineages, GATA1, NFE2 and LMO2 had similar expression level at all stages of differentiation. Level of TAL1 slightly increased upon differentiation, especially for the erythroid lineage. In contrast, the level of GATA2 was much higher in MEP and MK cell fractions than in the erythroid cell fraction, an expected finding as GATA2 plays a later role in MK than in erythroid differentiation. More surprisingly, MYB was detected during both differentiation with a tendency to be more expressed in MKs than in erythroid cells.
Nonetheless, expression levels of GATA2, MYB and also LMO2 was much lower at all differentiation stages compared to the other erythroid/MK genes. Considering the importance could thus discriminate the various cell clusters that were clearly separated ( Figure 6C ).
EPO is absolutely required for the primitive human embryonic erythropoiesis
In the mouse, it has been suggested that EPO was not a requirement for primitive erythropoiesis [35] [36] [37] . Thus, we evaluated the cytokine response of erythroid progenitors (GPA + CD41 -) purified from H1 hESC/OP9 co-culture at day 12. As shown in Figure 7A , EPO was absolutely required for Ery-P formation and its effect could not be replaced by SCF, IL-3 or TPO, as described in the mouse. IL-3, SCF and TPO had no synergy with EPO on the plating efficiency of Ery-P. However, a slight synergy was observed between EPO and IL-3, and to a lesser extent between EPO and SCF, leading to an increase in colony size, which could contain up to 200 hemoglobinized cells (Figure 7 B) . These "large" Ery-P colonies represented about 25% of the colonies growing in presence of EPO and IL-3. Figure S5 .
The expression level of MYB transcripts was quite surprising because levels in MEP, MK and erythroid cell fractions were similar, even with a decreasing trend in erythroid cells.
However the overall level of MYB expression was low but quite similar to that observed in adult or neonate progenitor. In the mouse, it has been demonstrated that MYB plays an important role in the commitment towards the erythroid lineage for the definitive might have an important role during primitive hematopoiesis, a hypothesis awaiting additional investigation.
In conclusion, the results presented herein provide the first evidence for the presence of a common megakaryocyte-erythroid progenitor in the primitive human embryonic hematopoiesis. These findings suggest that the close association between the erythroid and megakaryocytic lineages is conserved throughout the ontogeny of the human hematopoietic system. The model proposed in our study might be useful to dissect the mechanisms underlying erythroid and MK commitment as well as the differences between primitive and definitive hematopoiesis.
Acknowledgments
We 
7502.
For were sorted at day 12 of hES/OP9 co-culture and tested for colony-forming activity in presence of different combinations of cytokines, as indicated. Cytokines were used at the following concentrations: EPO, 2 U/mL; TPO, 50 ng/mL; SCF, 50 ng/mL and IL-3, 100 U/mL. Colonies were scored at day 9 of culture. The mean ± SD of 3 experiments is presented.
B: Morphology of Ery-P colonies grown with EPO alone (left) or with EPO plus IL-3 (right).
Note the difference in colony sizes. 
